Author:
Suzuki Shingo,Morishima Satoko,Murata Makoto,Tanaka Masafumi,Shigenari Atsuko,Ito Sayaka,Kanga Uma,Kulski Jerzy K.,Morishima Yasuo,Shiina Takashi
Abstract
Acute graft-versus-host disease (aGVHD) is defined as a syndrome of an immunological response of graft to the host that occurs early after allogeneic hematopoietic stem cell transplantation (HCT). This disease is frequently observed even in HCT matched for human leukocyte antigen (HLA) alleles at multiple gene loci. Although the HLA region represents complex and diverse genomic characteristics, detailed association analysis is required for the identification of uncharacterized variants that are strongly associated with aGVHD. We genotyped three loci, OR2H2, HLA-F-AS1, and HLA-G, that are located in the 460 kb of HLA telomeric region and statistically analyzed the genotypes including HLA-DPB1 with clinical and transplantation outcomes using 338 unrelated bone marrow transplantation (UR-BMT) patient–donor pairs who were matched for HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 (HLA-10/10). Multivariate analyses demonstrated that HLA-F-AS1 and HLA-DPB1 mismatches were associated with grade II–IV aGVHD (hazard ratio (HR), 1.76; 95% CI, 1.07–2.88; p = 0.026; and HR, 1.59; CI, 1.02–2.49; p = 0.042, respectively). There was no confounding between HLA-F-AS1 and HLA-DPB1 (p = 0.512), suggesting that the HLA-F-AS1 mismatch has a strong effect on aGVHD independently of HLA-DPB1. Moreover, a stratified analysis suggested possible associations of HLA-F-AS1, HLA-DPB1, and/or HLA-G mismatches with grade II–IV aGVHD and the more severe grade III–IV aGVHD. These findings provide new insights into understanding the molecular mechanism of aGVHD caused by HLA-matched UR-BMT.
Funder
Japan Society for the Promotion of Science
Japan Agency for Medical Research and Development
Subject
Immunology,Immunology and Allergy
Reference60 articles.
1. Analysis of 462 Transplantations From Unrelated Donors Facilitated by the National Marrow Donor Program;Kernan;N Engl J Med,1993
2. Effect of Matching of Class I HLA Alleles on Clinical Outcome After Transplantation of Hematopoietic Stem Cells From an Unrelated Donor. Japan Marrow Donor Program;Sasazuki;N Engl J Med,1998
3. Acute Graft Versus Host Disease;Jacobsohn;Orphanet J Rare Dis,2007
4. 1994 Consensus Conference on Acute GVHD Grading;Przepiorka;Bone Marrow Transplant,1995
5. Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation;Ratanatharathorn;Blood,1998